{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:54:10Z","timestamp":1761630850236},"reference-count":12,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2019,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>\n                           <jats:sup>18<\/jats:sup>F-Fluorocholine is a relatively new, extremely versatile radiotracer for detecting proliferative or mitogenic activity. Its diagnostic potential has been explored in cancers of the prostate, liver, esophagus, breast, brain, and lung, as well as lymphoma, sarcoma, melanoma, and parathyroid adenomas. The authors present a case where fluorocholine PET\/CT performed for characterizing a space-occupying lesion in the brain revealed intensely tracer-avid skull lesions with intracranial soft tissue component and multiple other skeletal lesions. Fine-needle aspiration cytology from the skull and chest wall lesions confirmed the diagnosis of plasma cell neoplasm.<\/jats:p>","DOI":"10.1097\/rlu.0000000000002415","type":"journal-article","created":{"date-parts":[[2018,12,18]],"date-time":"2018-12-18T19:17:53Z","timestamp":1545160673000},"page":"140-141","source":"Crossref","is-referenced-by-count":6,"title":["Incidental Detection of Plasma Cell Neoplasm on 18F-Choline PET\/CT Imaging"],"prefix":"10.1097","volume":"44","author":[{"given":"Jiwan","family":"Paudel","sequence":"first","affiliation":[{"name":"Nuclear Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Navneet","family":"Singla","sequence":"additional","affiliation":[{"name":"Neurosurgery, Postgraduate Institute of Medical Education and Research, Chandigarh, India."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anish","family":"Bhattacharya","sequence":"additional","affiliation":[{"name":"Nuclear Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajender Kumar","family":"Basher","sequence":"additional","affiliation":[{"name":"Nuclear Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bhagwant Rai","family":"Mittal","sequence":"additional","affiliation":[{"name":"Nuclear Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"bib1-20230928","doi-asserted-by":"crossref","first-page":"e491","DOI":"10.1097\/RLU.0000000000001845","article-title":"Comparative effectiveness of ultrasonography, 99mTc-sestamibi, and 18F-fluorocholine PET\/CT in detecting parathyroid adenomas in patients with primary hyperparathyroidism","volume":"42","year":"2017","journal-title":"Clin Nucl Med"},{"key":"bib2-20230928","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/RLU.0b013e3182867f3c","article-title":"Choline PET or PET\/CT and biochemical relapse of prostate cancer: a systematic review and meta-analysis","volume":"38","year":"2013","journal-title":"Clin Nucl Med"},{"key":"bib3-20230928","doi-asserted-by":"crossref","first-page":"e355","DOI":"10.1097\/RLU.0000000000001689","article-title":"18F-Fluorocholine PET\/CT complementing the role of dynamic contrast-enhanced MRI for providing comprehensive diagnostic workup in prostate cancer patients with suspected relapse following radical prostatectomy","volume":"42","year":"2017","journal-title":"Clin Nucl Med"},{"key":"bib4-20230928","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1097\/RLU.0000000000000817","article-title":"Incidental detection of a hodgkin lymphoma on 18F-choline PET\/CT and comparison with 18F-FDG in a patient with prostate cancer","volume":"40","year":"2015","journal-title":"Clin Nucl Med"},{"key":"bib5-20230928","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/RLU.0000000000001972","article-title":"Incidental detection of a melanoma by 18F-fluorocholine PET\/CT performed for evaluation of primary hyperparathyroidism","volume":"43","year":"2018","journal-title":"Clin Nucl Med"},{"key":"bib6-20230928","doi-asserted-by":"crossref","first-page":"e49","DOI":"10.1097\/JTO.0000000000000527","article-title":"Reply to \u201c18F-choline PET-CT in the management of lung cancer and mucinous tumors?\u201d","volume":"10","year":"2015","journal-title":"J Thorac Oncol"},{"key":"bib7-20230928","doi-asserted-by":"crossref","first-page":"4236","DOI":"10.1158\/1078-0432.CCR-10-0468","article-title":"Reproducibility of [11C]choline-positron emission tomography and effect of trastuzumab","volume":"16","year":"2010","journal-title":"Clin Cancer Res"},{"key":"bib8-20230928","first-page":"167","article-title":"Comparison of (11)C-choline and (18)F-FDG PET in primary diagnosis and staging of patients with thoracic cancer","volume":"43","year":"2002","journal-title":"J Nucl Med"},{"key":"bib9-20230928","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1046\/j.1365-2141.1999.01136.x","article-title":"Measurement of apoptosis and proliferation of bone marrow plasma cells in patients with plasma cell proliferative disorders","volume":"104","year":"1999","journal-title":"Br J Haematol"},{"key":"bib10-20230928","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1007\/s00259-010-1496-z","article-title":"PET with (18)F-labelled choline-based tracers for tumour imaging: a review of the literature","volume":"37","year":"2010","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib11-20230928","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/1477-7819-5-68","article-title":"11C-choline vs. 18F-FDG PET\/CT in assessing bone involvement in patients with multiple myeloma","volume":"5","year":"2007","journal-title":"World J Surg Oncol"},{"key":"bib12-20230928","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1007\/s00259-016-3392-7","article-title":"18F-fluorocholine versus 18F-fluorodeoxyglucose for PET\/CT imaging in patients with suspected relapsing or progressive multiple myeloma: a pilot study","volume":"43","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00003072-201902000-00012","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T03:22:30Z","timestamp":1695871350000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00003072-201902000-00012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":12,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000002415","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"value":"1536-0229","type":"electronic"},{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]}}}